These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

259 related articles for article (PubMed ID: 33062150)

  • 1. Prevention of Nonalcoholic Hepatic Steatosis by Shenling Baizhu Powder: Involvement of Adiponectin-Induced Inhibition of Hepatic SREBP-1c.
    Tang K; Deng Y; Zheng C; Nie H; Pan M; Chen R; Xie J; Yang Q; Zhang Y
    Oxid Med Cell Longev; 2020; 2020():9701285. PubMed ID: 33062150
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Shenling Baizhu powder alleviates non-alcoholic fatty liver disease by modulating autophagy and energy metabolism in high-fat diet-induced rats.
    Pan M; Deng Y; Qiu Y; Pi D; Zheng C; Liang Z; Zhen J; Fan W; Song Q; Pan J; Li Y; Yan H; Yang Q; Zhang Y
    Phytomedicine; 2024 Jul; 130():155712. PubMed ID: 38763008
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Diosgenin alleviates NAFLD induced by a high-fat diet in rats via mTOR/SREBP-1c/HSP60/MCAD/SCAD signaling pathway].
    Chen SW; Yin GL; Song CY; Meng DC; Yu WF; Zhang X; Feng YN; Liang PP; Zhang FX
    Zhongguo Zhong Yao Za Zhi; 2023 Oct; 48(19):5304-5314. PubMed ID: 38114120
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Alisol A 24-Acetate Prevents Hepatic Steatosis and Metabolic Disorders in HepG2 Cells.
    Zeng L; Tang W; Yin J; Feng L; Li Y; Yao X; Zhou B
    Cell Physiol Biochem; 2016; 40(3-4):453-464. PubMed ID: 27889747
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diosgenin ameliorates palmitic acid-induced lipid accumulation via AMPK/ACC/CPT-1A and SREBP-1c/FAS signaling pathways in LO2 cells.
    Fang K; Wu F; Chen G; Dong H; Li J; Zhao Y; Xu L; Zou X; Lu F
    BMC Complement Altern Med; 2019 Sep; 19(1):255. PubMed ID: 31519174
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Zhimu-Huangbai herb-pair ameliorates hepatic steatosis in mice by regulating IRE1α/XBP1s pathway to inhibit SREBP-1c.
    Zhao W; Wang X; Nie W; Jiang M; Zhao Y; Zhang T; Ding Y
    Phytomedicine; 2024 Nov; 134():156017. PubMed ID: 39265443
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Effect of Fuzi Lizhong decoction in reducing liver injury of rats with non-alcoholic fatty liver via activating AMPK and suppressing NF-κBp65 pathway].
    Yang JY; Shi ZH; Ma W; Tao DQ; Liu S; Chen L; Zhou XL
    Zhongguo Zhong Yao Za Zhi; 2018 Aug; 43(15):3176-3183. PubMed ID: 30200715
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chinese herbal medicine mixture 919 syrup alleviates nonalcoholic fatty liver disease in rats by inhibiting the NF-κB pathway.
    Chen M; Xing J; Pan D; Peng X; Gao P
    Biomed Pharmacother; 2020 Aug; 128():110286. PubMed ID: 32521450
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The chloroform extract of Cyclocarya paliurus attenuates high-fat diet induced non-alcoholic hepatic steatosis in Sprague Dawley rats.
    Lin Z; Wu ZF; Jiang CH; Zhang QW; Ouyang S; Che CT; Zhang J; Yin ZQ
    Phytomedicine; 2016 Nov; 23(12):1475-1483. PubMed ID: 27765368
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Berberine attenuates nonalcoholic hepatic steatosis through the AMPK-SREBP-1c-SCD1 pathway.
    Zhu X; Bian H; Wang L; Sun X; Xu X; Yan H; Xia M; Chang X; Lu Y; Li Y; Xia P; Li X; Gao X
    Free Radic Biol Med; 2019 Sep; 141():192-204. PubMed ID: 31226399
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Therapeutic effects of granulocyte-colony stimulating factor on non-alcoholic hepatic steatosis in the rat.
    Song YS; Fang CH; So BI; Park JY; Jun DW; Kim KS
    Ann Hepatol; 2013; 12(1):115-22. PubMed ID: 23293202
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Betaine attenuates chronic alcohol‑induced fatty liver by broadly regulating hepatic lipid metabolism.
    Yang W; Huang L; Gao J; Wen S; Tai Y; Chen M; Huang Z; Liu R; Tang C; Li J
    Mol Med Rep; 2017 Oct; 16(4):5225-5234. PubMed ID: 28849079
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of the new thiazolidine derivative LPSF/GQ-02 on hepatic lipid metabolism pathways in non-alcoholic fatty liver disease (NAFLD).
    Araújo S; Soares E Silva A; Gomes F; Ribeiro E; Oliveira W; Oliveira A; Lima I; Lima MDC; Pitta I; Peixoto C
    Eur J Pharmacol; 2016 Oct; 788():306-314. PubMed ID: 27349145
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dietary sea cucumber cerebroside alleviates orotic acid-induced excess hepatic adipopexis in rats.
    Zhang B; Xue C; Hu X; Xu J; Li Z; Wang J; Yanagita T; Xue Y; Wang Y
    Lipids Health Dis; 2012 May; 11():48. PubMed ID: 22569330
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Deoxypodophyllotoxin in Anthriscus sylvestris alleviates fat accumulation in the liver via AMP-activated protein kinase, impeding SREBP-1c signal.
    Kim KY; Park KI; Lee SG; Baek SY; Lee EH; Kim SC; Kim SH; Park SG; Yu SN; Oh TW; Kim JH; Kim KJ; Ahn SC; Kim YW
    Chem Biol Interact; 2018 Oct; 294():151-157. PubMed ID: 30148990
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oxymatrine alleviated hepatic lipid metabolism via regulating miR-182 in non-alcoholic fatty liver disease.
    Zhang H; Yang L; Wang Y; Huang W; Li Y; Chen S; Song G; Ren L
    Life Sci; 2020 Sep; 257():118090. PubMed ID: 32679144
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hepatic differentiated embryo-chondrocyte-expressed gene 1 (Dec1) inhibits sterol regulatory element-binding protein-1c (Srebp-1c) expression and alleviates fatty liver phenotype.
    Shen L; Cui A; Xue Y; Cui Y; Dong X; Gao Y; Yang H; Fang F; Chang Y
    J Biol Chem; 2014 Aug; 289(34):23332-42. PubMed ID: 24993831
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Kangtaizhi Granule Alleviated Nonalcoholic Fatty Liver Disease in High-Fat Diet-Fed Rats and HepG2 Cells via AMPK/mTOR Signaling Pathway.
    Zhang J; Du H; Shen M; Zhao Z; Ye X
    J Immunol Res; 2020; 2020():3413186. PubMed ID: 32884949
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Polydatin alleviates non-alcoholic fatty liver disease in rats by inhibiting the expression of TNF-α and SREBP-1c.
    Zhang J; Tan Y; Yao F; Zhang Q
    Mol Med Rep; 2012 Oct; 6(4):815-20. PubMed ID: 22858825
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Investigating the effects of compound WS090152 on non-alcoholic fatty liver in mice].
    Zhou Y; Li XL; Yi Q; Zhang XL; Tian JY; Wang DM; Wu S; Ye F
    Yao Xue Xue Bao; 2016 Jun; 51(6):919-25. PubMed ID: 29879345
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.